News

News

McMasters Gives Moving Speech on Palliative ‘Treatment’ vs ‘Care’
UofL-founded company secures $100 million to advance cell therapy to improve organ transplant outcomes
UofL researcher developing drug to treat emerging encephalitis viruses
NIH dedicates $21 million to prepare antiviral drug for clinical trials
RAS Inhibitor Cancer Drug Licensed to California Medical Company by University of Louisville (UofL)
PhTx graduate student receives first place award for research poster presentation at annual Experimental Biology meetings
Immunotherapy drug gives colon cancer patient another chance at life
First approved for melanoma, Keytruda® now can be used with several types of cancer
Moving Closer to Cancer Prevention
UofL Cancer-Targeting Technology Licensed to California Medical Company
Metabolite Produced by Gut Microbiota from Pomegranates Reduces Inflammatory Bowel Disease
Prevent sports-related eye injuries
Gift to UofL aids research into biomarkers for cardiovascular disease
Late James Ryan made donation to lab of Andrew DeFilippis, M.D.
UofL Cancer Education Program Alumni Present Research at ACC Meetings of the Minds
Pharmacology and Toxicology PhD students receive major travel awards to present research
Kentucky has highest child abuse rate in the U.S.; caregivers can help
More than 150 girls expected at first UofL STEM+H event
School of Medicine co-hosts event to interest girls in science, technology, engineering, mathematics and health careers
Where to seek care when you’re sick or injured
UofL doctors discuss health care options
Disaster Medicine Certificate Series hosts active shooter disaster drill Saturday, March 30
Bystanders should be aware of visual, sound effects and avoid area unless necessary.
Internationally renowned genomicist to give public talk on application of big data to human health
2019 Research Grant Awards
The perfect match - medical students prep for their next phase of medical training